BackBackCash from financing activities of Agios Pharmaceuticals, Inc.
Annual data
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
−900.00 M
−600.00 M
−300.00 M
0.00
300.00 M
Period
Value
Change
Change %
TTM
10.45 M
+5.01 M
+92.29%
2023
5.43 M
+3.08 M
+131.19%
2022
2.35 M
+768.12 M
-
2021
−765.77 M
−1.03 B
−392.82%
2020
261.52 M
−28.09 M
−9.70%
2019
289.61 M
−256.41 M
−46.96%
Quarterly data
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
1.50 M
3.00 M
4.50 M
6.00 M
Period
Value
Change
Change %
Q3 '24
2.64 M
+1.54 M
+139.95%
Q2 '24
1.10 M
−4.76 M
−81.26%
Q1 '24
5.86 M
+5.02 M
+592.33%
Q4 '23
847.00 K
−1.03 M
−54.99%
Q3 '23
1.88 M
+1.65 M
+694.09%
Q2 '23
237.00 K
−2.23 M
−90.39%
Q1 '23
2.47 M
+2.44 M
+11.11 K%
Q4 '22
22.00 K
−1.17 M
−98.15%